Immune Checkpoint Inhibitors Tested in Triple-Negative Breast Cancer
The landscape of triple-negative breast cancer (TNBC) treatment is witnessing a transformative shift with the rising prominence of immune checkpoint inhibitors (ICIs). A recent systematic...
















